Loading
Sections

Skip to content. | Skip to navigation

You are here: Home > Latest News

News

Collin Peterjohn: A Profound Opportunity for a Second Chance

Collin Peterjohn: A Profound Opportunity for a Second Chance

A 25-year-old Charlotte man gets a second chance at life with a profound recovery from serious lung injuries sustained in a fire that left his family homeless.

Read More…

Chelminski, Meltzer-Brody named first Sanders Clinician Scholars

Chelminski, Meltzer-Brody named first Sanders Clinician Scholars

As the first two Sanders Clinician Scholars, Paul Chelminski, MD, MPH, and Samantha Meltzer-Brody, MD, MPH, will develop educational efforts to enhance supportive direct personal contact to the daily care of patients, and to teach others to do the same.

Read More…

Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research

Norman E. Sharpless, MD, appointed the Wellcome Distinguished Professor in Cancer Research

The professorship was established by the School of Medicine in 1988 with gifts from the Burroughs Wellcome Fund and the William A. Smith Trust of Wadesboro, N.C.

Read More…

Grant to fund use of kinase test in HER2-positive breast cancer

Grant to fund use of kinase test in HER2-positive breast cancer

Susan G. Komen for the Cure® has awarded a grant of almost $900,000 to Lisa A. Carey, MD, and Gary Johnson, PhD, to research clinical applications for the first broad-based test for protein kinase activation and response to inhibitory drugs in HER2-positive breast cancer.

Read More…

DNA replication protein also has a role in mitosis, cancer

DNA replication protein also has a role in mitosis, cancer

The finding presents a possible explanation for why so many cancers possess not just genomic instability, but also more or less than the usual 46 DNA-containing chromosomes.

Read More…

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

Molecular subtypes and genetic alterations may determine response to lung cancer therapy

A UNC-led team of scientists has shown for the first time that lung cancer molecular subtypes correlate with distinct genetic alterations and with patient response to therapy.

Read More…

New study shows benefit of new maintenance therapy for multiple myeloma

New study shows benefit of new maintenance therapy for multiple myeloma

Dr. Thomas Shea and Dr. Don Gabriel of UNC are co-authors of the study, which offers promising news about a new long-term therapy, lenalidomide, that can be used after transplantation to slow down the progression of the disease.

Read More…

UNC Bone Marrow and Stem Cell Transplantation Program achieves outstanding outcomes

UNC Cancer Care’s Bone Marrow and Stem Cell Transplantation Program is one of only 14 out of 156 centers across the country to be rated an “overperforming” center.

Read More…

Nutrition Research Institute receives Grand Challenges Explorations Grant for global health research

Nutrition Research Institute receives Grand Challenges Explorations Grant for global health research

The University of North Carolina at Chapel Hill’s Nutrition Research Institute in Kannapolis is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

Read More…

real doctors, real people - Eric Juengst

real doctors, real people - Eric Juengst

Eric Juengst, PhD, directs the UNC Center for Bioethics. He also makes armor. Yep, the kind knights would wear while protecting their king's domain.

Read More…

Stem cells poised to self-destruct for the good of the embryo

Stem cells poised to self-destruct for the good of the embryo

Embryonic stem cells are primed to kill themselves if damage to their DNA makes them a threat to the developing embryo. UNC researchers reveal how they do it.

Read More…

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery

A team of UNC researchers developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.

Read More…

Scientists awarded $2.4 million to study genetic variation in people with diabetes

Scientists awarded $2.4 million to study genetic variation in people with diabetes

The goal of the study is to identify genetic variations that may help predict the response to various treatment options for type 2 diabetes to reduce cardiovascular disease.

Read More…

Patient survival not impacted by liver transplants performed at night or on weekends

Patient survival not impacted by liver transplants performed at night or on weekends

A new study led by Dr. A. Sidney Barritt IV of UNC shows that liver transplants performed at night or on weekends do not adversely affect patient or graft survival.

Read More…

Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies

Longer breastfeeding along with antiretroviral drugs could lower HIV transmission to babies

New research finds that early weaning – stopping breastfeeding before six months – is of little, if any, protective value against HIV transmission nor is it safe for infant survival.

Read More…

Stanford and MIT scientists win Perl-UNC Neuroscience Prize

Stanford and MIT scientists win Perl-UNC Neuroscience Prize

The Perl prize carries a $10,000 award and is given to recognize a seminal achievement in neuroscience. Past recipients have included four subsequent winners of the Nobel Prize for Physiology and Medicine.

Read More…

New book summarizes state of eHealth applications

New book summarizes state of eHealth applications

UNC’s Seth Noar examines intersection of technology and health

Read More…

RN: Real Nurses - Suzy Lawrence

RN: Real Nurses - Suzy Lawrence

Suzy Lawrence, a nurse in UNC Gynecologic Oncology, takes an environmentally aware approach to the way she lives.

Read More…

Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment

Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment

UNC researchers describe how exploiting the molecular mechanism behind acupuncture resulted in six-day pain relief in animal models. They call this new therapeutic approach PAPupuncture.

Read More…

International panel recommends new model for breast cancer care

International panel recommends new model for breast cancer care

Deborah K. Mayer of UNC co-authored two articles addressing cancer-related fatigue and chemotherapy-induced peripheral neuropathy (nerve damage).

Read More…